| JAK-STAT信号通路及其抑制剂在特应性皮炎治疗中的应用 |
| |
| 引用本文： | 张曾云鸥蔡新颖,肖风丽. JAK-STAT信号通路及其抑制剂在特应性皮炎治疗中的应用[J]. 中华皮肤科杂志, 2020, 53(8): 661-664. DOI: 10.35541/cjd.20190282 |
| |
| 作者姓名： | 张曾云鸥蔡新颖 肖风丽 |
| |
| 作者单位： | 安徽医科大学第一附属医院皮肤性病科安徽医科大学皮肤病研究所,合肥230022 |
| |
| 基金项目： | 安徽省自然科学基金（1708085MH217）;安徽省学术和技术带头人及后备人选学术科研活动资助项目（2017D141） |
| |
| 摘 要： | 【摘要】 Janus激酶信号转导和转录激活因子（JAK-STAT）信号通路在特应性皮炎（AD）免疫学通路中起着重要作用,阻断JAK-STAT信号通路的药物,如经典的JAK抑制剂托法替尼、鲁索利替尼等,已逐步应用到AD治疗的临床试验中,并取得较好的疗效。其他对JAK-STAT信号通路有抑制作用的因子,如apamin、dupilumab等也在治疗AD上显示出一定效果。本文对近年来JAK-STAT信号通路及其相关抑制剂研究进行综述。
|
| 关 键 词： | 皮炎 特应性 Janus激酶类 STAT转录因子类 JAK/STAT抑制剂 |
| 收稿时间： | 2019-01-31 |
JAK-STAT signaling pathway and its inhibitors in the treatment of atopic dermatitis |
| |
| zhangZhang Zengyunou,Cai Xinying,Xiao Fengli. JAK-STAT signaling pathway and its inhibitors in the treatment of atopic dermatitis[J]. Chinese Journal of Dermatology, 2020, 53(8): 661-664. DOI: 10.35541/cjd.20190282 |
| |
| Authors: | zhangZhang Zengyunou Cai Xinying Xiao Fengli |
| |
| Affiliation: | Department of Dermatology and Venereology, The First Affiliated Hospital of Anhui Medical University, Institute of Dermatology, Anhui Medical University, Hefei 230022, China |
| |
| Abstract: | 【Abstract】 Janus kinase-signal transducer and activator of transcription （JAK-STAT） signaling pathway plays an important role in immune pathways in atopic dermatitis （AD）. Drugs that block the JAK-STAT signaling pathway, such as classic JAK inhibitors tofacitinib, ruxolitinib, etc., have been gradually applied to the treatment of AD in clinical trials, and good clinical efficacy has been achieved. In addition, other inhibitors of the JAK-STAT signaling pathway, such as apamin and dupilumab, also show some efficacy in the treatment of AD. This review summarizes recent studies on the JAK-STAT signaling pathway and its inhibitors. |
| |
| Keywords: | Dermatitis atopic Janus kinases STAT transcription factors JAK/STAT inhibitor |
|
| 点击此处可从《中华皮肤科杂志》浏览原始摘要信息 |
|
点击此处可从《中华皮肤科杂志》下载全文 |
